ST
DGX icon

Sabal Trust’s Quest Diagnostics DGX Stock Holding History

Sabal Trust’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,756
Closed -$210K – 152
2020
Q4 		$210K Sell
1,756
-172,451
-99% -$21M 0.02% 143
2020
Q3 		$19.9M Sell
174,207
-7,755
-4% -$916K 1.74% 28
2020
Q2 		$20.7M Sell
181,962
-7,364
-4% -$781K 1.94% 27
2020
Q1 		$15.2M Sell
189,326
-10,944
-5% -$1.13M 1.71% 31
2019
Q4 		$21.4M Buy
200,270
+3,852
+2% +$402K 1.7% 39
2019
Q3 		$21M Buy
196,418
+2,766
+1% +$284K 1.7% 37
2019
Q2 		$19.7M Buy
+193,652
New +$18.6M 1.74% 35
2018
Q2 		– Sell
-2,596
Closed -$260K – 143
2018
Q1 		$260K Buy
+2,596
New +$266K 0.02% 141

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Sabal Trust's DGX Position: Q1 2021 in Review

Sabal Trust sold out of Quest Diagnostics (DGX) in Q1 2021, closing a stake of 1,756 shares — an estimated $210K sold.

Sabal Trust first reported a position in DGX in Q1 2018 and held it in 8 quarters. The position peaked at $21.4M in Q4 2019. 817 funds tracked by Wall St. Rank hold DGX as of Q1 2021.

  • Sabal Trust reported no remaining Quest Diagnostics position as of Q1 2021 after selling out during the quarter.
  • Sabal Trust sold 1,756 Quest Diagnostics shares in Q1 2021, an estimated $210K.
  • Sabal Trust first reported a position in Quest Diagnostics in Q1 2018 and held it in 8 quarters.
  • Sabal Trust's Quest Diagnostics position peaked at $21.4M in Q4 2019.
  • 817 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2021.

Based on Sabal Trust's 13F filing for Q1 2021, filed 19 Apr 2021.